BACKGROUND: Rest and rest-redistribution thallium 201 myocardial perfusion single photon emission computed tomography (SPECT) (MPS) has been incompletely validated in patients for determination of the total amount of scarred myocardium. We sought to determine whether rest or redistribution Tl-201 MPS provides an accurate determination of infarct size as defined by delayed contrast-enhanced cardiac magnetic resonance (CMR). METHODS AND RESULTS: We studied patients (n = 44) with chronic coronary artery disease referred for rest-redistribution Tl-201 MPS, who were also studied by contrast-enhanced CMR within 3 +/- 4 days. Patients were considered retrospectively based on a series of patients referred for clinically indicated MPS. Defect size, as a percent of left ventricular mass (% LV), was determined by quantitative perfusion SPECT (QPS) and compared with the volume of delayed hyperenhancement on contrast-enhanced CMR, normalized to LV mass. Infarct size varied from 0% to 43% LV. Rest QPS defect size correlated with the amount of nonviable myocardium assessed by contrast-enhanced CMR (r = 0.76; mean difference, 4.3% +/- 8.0% LV). When delayed thallium data were considered, redistribution QPS was superior to rest QPS for determination of infarct size (redistribution r = 0.90; mean difference, 2.4% +/- 5.2% LV; P = .03 vs rest). CONCLUSION: Rest-redistribution Tl-201 MPS provides a more accurate measurement of total infarct size than rest-only Tl-201 MPS and correlates with contrast-enhanced CMR.
BACKGROUND: Rest and rest-redistribution thallium 201 myocardial perfusion single photon emission computed tomography (SPECT) (MPS) has been incompletely validated in patients for determination of the total amount of scarred myocardium. We sought to determine whether rest or redistribution Tl-201 MPS provides an accurate determination of infarct size as defined by delayed contrast-enhanced cardiac magnetic resonance (CMR). METHODS AND RESULTS: We studied patients (n = 44) with chronic coronary artery disease referred for rest-redistribution Tl-201 MPS, who were also studied by contrast-enhanced CMR within 3 +/- 4 days. Patients were considered retrospectively based on a series of patients referred for clinically indicated MPS. Defect size, as a percent of left ventricular mass (% LV), was determined by quantitative perfusion SPECT (QPS) and compared with the volume of delayed hyperenhancement on contrast-enhanced CMR, normalized to LV mass. Infarct size varied from 0% to 43% LV. Rest QPS defect size correlated with the amount of nonviable myocardium assessed by contrast-enhanced CMR (r = 0.76; mean difference, 4.3% +/- 8.0% LV). When delayed thallium data were considered, redistribution QPS was superior to rest QPS for determination of infarct size (redistribution r = 0.90; mean difference, 2.4% +/- 5.2% LV; P = .03 vs rest). CONCLUSION: Rest-redistribution Tl-201 MPS provides a more accurate measurement of total infarct size than rest-only Tl-201 MPS and correlates with contrast-enhanced CMR.
Authors: T Sharir; D S Berman; H C Lewin; J D Friedman; I Cohen; R Miranda; R D Agafitei; G Germano Journal: Circulation Date: 1999-11-09 Impact factor: 29.690
Authors: Li-Yueh Hsu; Alex Natanzon; Peter Kellman; Glenn A Hirsch; Anthony H Aletras; Andrew E Arai Journal: J Magn Reson Imaging Date: 2006-03 Impact factor: 4.813
Authors: M A Lawson; L L Johnson; L Coghlan; M Alami; E L Tauxe; S E Reinert; R Singleton; G M Pohost Journal: Am J Cardiol Date: 1997-08-15 Impact factor: 2.778
Authors: A Rozanski; D S Berman; R Gray; R Levy; M Raymond; J Maddahi; N Pantaleo; A D Waxman; H J Swan; J Matloff Journal: Circulation Date: 1981-11 Impact factor: 29.690
Authors: Fatma Aboul-Enein; Saibal Kar; Sean W Hayes; Maria Sciammarella; Aiden Abidov; Raj Makkar; John D Friedman; Neal Eigler; Daniel S Berman Journal: J Nucl Med Date: 2004-06 Impact factor: 10.057
Authors: Sigurdur S Stephensen; Marcus Carlsson; Martin Ugander; Henrik Engblom; Goran Olivecrona; David Erlinge; Hakan Arheden Journal: BMC Med Imaging Date: 2010-01-24 Impact factor: 1.930
Authors: Lene Rosendahl; Peter Blomstrand; Jan L Ohlsson; Per-Gunnar Björklund; Britt-Marie Ahlander; Sven-Ake Starck; Jan E Engvall Journal: BMC Med Imaging Date: 2008-12-12 Impact factor: 1.930